• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Teva Pharmaceuticals

Teva appoints former Vertex exec as new head of R&D, CMO

July 1, 2022 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) announced today that it appointed Dr. Eric A. Hughes as VP of global R&D and chief medical officer. Hughes’ employment becomes effective Aug. 1, 2022, and he will be based out of Tel Aviv, Israel-based Teva’s U.S. headquarters in Parsippany, New Jersey. Get the full story at our sister site, Drug Delivery Business […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Pharmaceutical Tagged With: Personnel Moves, Teva Pharmaceuticals

Teva rises on mixed-bag Q4, sets 2022 guidance

February 9, 2022 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) shares ticked up this morning on fourth-quarter results that topped the consensus EPS forecast. The Tel Aviv, Israel-based company posted losses of $159 million, or 14¢ per share, on sales of $4.1 billion for the three months ended Dec. 31, 2021, for a bottom-line slide into the red on a sales decline of […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Teva Pharmaceuticals

Teva announces two offerings worth $7.5 billion, dips on missed Q3 projections

October 27, 2021 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) shares took a hit today on third-quarter results that fell short of the consensus forecast. TEVA shares were down -4.7% at $8.95 per share in mid-morning trading. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -0.8%. Get the full story at our sister site, Drug […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, MassDevice Earnings Roundup, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Teva Pharmaceuticals

Teva initiates U.S. recall of Topotecan metastatic ovarian cancer injection treatment

July 1, 2021 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) initiated a voluntary recall of a lot of its Topotecan injection 4mg/4mL (1mg/mL) in the U.S. The voluntary recall came as a result of a complaint received from a pharmacy after a single glass particle was observed inside one vial. Following further examination of the complaint sample, two other particulates were found and […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Oncology, Pharmaceutical, Recalls, Regulatory/Compliance Tagged With: FDA, Teva Pharmaceuticals

Teva launches first U.S. generic Perforomist inhaled COPD treatment

June 23, 2021 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) announced the U.S. launch of the first generic version of the twice-daily Perforomist inhalation solution. Parsippany, N.J.-based Teva Pharmaceuticals — a U.S. affiliate of Tel Aviv, Israel-based Teva Pharmaceutical Industries Ltd. — launched the formoterol fumarate inhalation solution (20 mcg/2 mL) with an indication for treating bronchoconstriction in patients with chronic obstructive pulmonary […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceutical, Respiratory Tagged With: Teva Pharmaceuticals

Teva Pharmaceuticals unchanged before hours on Q1 earnings beat

April 28, 2021 By Sean Whooley

Teva Pharmaceuticals (NYSE:TEVA) shares stood firm before hours today on first-quarter earnings that topped the consensus forecast. The Tel Aviv, Israel-based company posted profits of $84 million, or 7¢ per share, on sales of $4 billion for the three months ended March 31, 2021, for a more-than tripled bottom-line despite a sales decline of -8.6%. Get […]

Filed Under: Business/Financial News, Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceutical, Respiratory, Wall Street Beat Tagged With: Teva Pharmaceuticals

Teva Pharmaceuticals receives European approval for Spiromax inhalers

April 8, 2021 By Sean Whooley

Teva Pharmaceuticals announced today that it received European marketing authorization for its Seffalair and BroPair Spiromax inhalers. Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ fluticasone propionate, 12.75/100 and 12.75/202 micrograms delivered doses) received approval as a maintenance treatment for asthma in adults and adolescents aged 12 years and older, according to a news release. […]

Filed Under: Business/Financial News, Drug-Device Combinations, Pharmaceutical, Regulatory/Compliance, Respiratory Tagged With: Teva Pharmaceuticals

8 drug delivery innovations you need to know

February 25, 2021 By Sean Whooley

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]

Filed Under: Business/Financial News, Drug Pumps, Drug-Device Combinations, Featured, Pharmaceutical Tagged With: dyvebioscience, Enable Injections, evoxtherapeutics, Inovio Pharmaceuticals, Johns Hopkins, Lyra Therapeutics, Medtronic, Tandem Diabetes Care, Teva Pharmaceuticals, Teva Respiratory

Amazon, Onica to support digital health for Teva’s Digihaler

October 22, 2020 By Sean Whooley

Teva Respiratory (NYSE:TEVA) announced that it is collaborating with Amazon Web Services (AWS) and Onica to build and host its digital health platform. The Teva Pharmaceuticals affiliate’s digital health platform is a cloud-based backend data system designed to support its FDA-approved Digihaler portfolio of breath-actuated digital inhalers and its companion mobile app that tracks inhaler events […]

Filed Under: Digital Health, Drug-Device Combinations, Featured, Health Technology, Pharmaceutical, Respiratory Tagged With: Amazon, Onica, Teva Pharmaceuticals

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

Feds accuse Teva of $300M in kickbacks for MS drug

August 18, 2020 By Nancy Crotti

Massachusetts federal prosecutors today claimed that Teva Pharmaceuticals funneled $300 million from a pair of charitable foundations to subsidize Medicare copayments for a multiple sclerosis drug. Teva Pharmaceuticals and Teva Neuroscience, the maker of Copaxone, simultaneously raised the drug’s price by 329%, allegedly violating the Anti-Kickback Statute and False Claims Act, according to the complaint filed by the U.S. […]

Filed Under: Business/Financial News, Legal News, Pharmaceutical Tagged With: Teva Neuroscience, Teva Pharmaceuticals

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 7
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS